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Silent myocurdia ischcmia is increasingly becoming rccog 
nixed as an importatnt ~\inicd manifestation in patients with 
atherosclerotic coronary artcry disease Iktinsil as the ok- 
jective evidence ofischcmia without symptoms, silent ischc- 
miw hns been cstimntcd to occur in about 2.5% of persons 
without previous manifestations of coronary artcry disease 
(I ,2) and in 25% to 34% of patients with significant coronary 
atherosclerosis (3-5). Among patients with unstable angina 
pectoris, 50% experience silent ischcmia (6). and up to 92% 
of ischcmic episodes may occur without symptoms (6.7). 
enesls of silent ischemia. The mechanism and 
sis of silent myocardial ischemia are currently 
unresolved. Three proposed mechanisms of silent ischsmia 
are altered neural pathways, insufficient ischcmia to reach 
the angina1 threshold and an abnormally high threshold of 
pain (3). Cardiac transplant patients with surgical dcnerva- 
(ion of the heart at the time of implantation and diabetic 
patients with pcriphorul ncuropathy are two important 
groups of patients who expcricnce silent ischemia because of 
altered neurologic pathways, However. thcsr: puticnts mny 
e anginaI equivalents such as dyspnoa and. hence. 
a may not be totally clinically silent, The potential 
for an ischemic episode to be of insufficient duration or 
severity to reach the angina1 threshold has heun shown in 
p&m undergoing coronary anyisglasty (XL After balloon 
wclusion of the coronary artery, chest pttin is delayed for 20 
to 30 S. Before the onset of chest pain, however, diastolic 
relaxation and systolic contraction are reduced, diastolic 
6liing pressure is increased and typical clectrocardiolo~ic 
(ECC) ckunges of myocardial ischemia occur. 
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significantly shorter and associated with less S 
deviation compared with symptomatic episodes. 
other investigators (9.10) have failed to show that as~~~to~ 
matic &hernia is less severe than symptomatic ischemia. In 
patients with proved coronary artery disease, Stern et al. (9) 
reported that symptomatic and asym 
ischemia were simil 
amounts of ST segme 
rno~itori~~~. Si~~~~arly, 
asymptomatic and symp 
by angioplasty balio 
similar reduction in 
function rind were equal in dMr~~tioo. 
??v ikicrlcc .fi)r ahred pcrin t~tr~ls~~~~l~ as u t}~~~~~~l~~ti~~t~~ ,tbr
silant isckmicr wt s~~}l~~~~~~~(l~ .~~~~ ~~~~~~ m wdl. ~~~ 
investigators ( I I) have noted that pl~~srn~~ cndo 
are higher after exercise in patients witb silent 
ischemia than m patients who experi~nccd a 
cxcrtion. Others (12) have noted that nalox 
antagonist. does not influence whether an is 
is accom~~~icd by a~~ioa~ s~~~esti 
dorphins may not be important in al 
in patients with silent ischemia. 
ischcmia precipitated by me 
pressor test (14) resulted in 
blood flow as assessed by 
tomo~r~~phy. Furthermore, the heart rate at the onset o 
pressor-provoked silent ischemje was significantly 
than that during exercise-induced &hernia ( W. however, a 
study by Rozanski et al. (15) s~~~estcd that increased 
myocardial oxygen demand may be an important factor in 
silent myocardial iscbemiu. Silent ischcmiu precipitated by 
mental stress was associated with an increase in systolic and 
diastolic blood pressures that was roughly equivalent to the 
increase seen with exercise-induced ischemia. Similarly, 
Langer et al. (7) noted that the rate-pressure product in- 
creased si~nificantl~~ before and during asymptomatic epi- 
sodes of ischemia in I% patients with unstable angina. 
The ~~ese~~ study. In this issue of the Journal, Breiten- 
biicher et al. (I(i) report that the incidence of myocardial 
infarction or death was significantly greater in patients wit 
silent my~ard~a~ ischemia than in patients with sympto- 
matic angina pectoris. Of 140 atients who had a positive 
exercise radionuclide ventriculogram. 84 (56%) did not expe- 
rience angina during exercise. Of the 84 patients with silent 
ischemia. I2 (14%) had a subsequent myocardial infarction 
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at the survival rate of 
period (53 c 7% versus 
y treated ~atje~~ts with 
a ssmilar pro~~osjs whether they 
ischemia demo~str~~ted by ambulatory elcctrocardi~~ra~~ly 
(19) or exercise thallium scintigraphy (201 bad a poorer 
prognosis compared with patients with exercise-induced 
myocardial ischemia. De Wood 9) reported a 23% 3 year 
mortality rate in 26 patients wit silent ischcmia c~~rn~ared 
with a 6.2% mortality rate in at~c~ts w~t~~)~t silent 
ischemia. Bn a small group of patients, Assey et al. (20) 
reported an intireased incidence myocardial jafarct~on in 
patlents with silent exercise-in ed k-hernia who were 
hollowed up for 38 months. Six (22%) oftheir 27 patients with 
silent ischemia experienced an infarction compared with B 
(4%) of 28 patients in the group with angina (p = 0.05). 
In patients with unstabk angina pcx%xis. the demonstra- 
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strated that the prest..-e or absence of ST segment shifts on 
Halter monitoring stratified patients into high risk and IoW 
risk groups, A similar approach with repealed ambulatory 
Holter monitoring or repeated exercise testing would be 
helpful to assess the impact of medical and surgical therapy 
in patients with silent ischemia. 
plkations of the study. This study (16) and others 
su st that the prognosis of patients with silent myocardial 
ischemia is not better than that of patients with symptomatic 
, Although the data suggest that patients 
ly may have a better outcome than that of 
medically, the study fails to identify subsets 
of patients in whom sur al therapy would be most beneh- 
ciul, ~urth~r~~or~, it is ssiblc that the less than maximal 
rn~dic~~l therapy received by the patients with silent ischemia 
e\y have accounted for the poorer prognosis in this group, 
owever, this study does raise the question as to whether 
medical therapy is adequate for patients with silent ischemia. 
Alth previous i~vestig~~tors (3.22.23) have suggested 
that tes, calcium blockers and beta-blockers arc etYec- 
tive in decreasing episodes of silent ischcmia. they have not 
addressed the impact of adequate medical therapy on prog- 
nods, Furthermore, this study (16) illustrates the need for 
prospective trials to define subsets of patients with major 
risk for s ’ us ischemic events and the need to test the 
impact of ressive medical thetapy and revascularization 
on prognosis in patients with coronary artcry discasc who 
have silent myocardial ischemia. 1 believe that because 
active ischemia, whether silent or manifest, adversely &‘ccts 
prognosis, it should be treated apgressivcly. Although sur- 
gical r~v~sctllari~ution (WI 1 and coronary halloon an&- 
plasty (24) wro very ctI&tive in alleviating ischcmia, mrdical 
otter monitoring or cxcrcisc 
tivc in many patients. Re- 
rved for patients who have 
medical therapy by objective criteriu or for 
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